01/21/2025
4:09 PM | Xilio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/19/2024
3:15 PM | GILEAD SCIENCES, INC. (Filed by)
Xilio Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
12/19/2024
3:19 PM | GILEAD SCIENCES, INC. (Reporting)
Xilio Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2024
6:45 AM | Xilio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
4:44 PM | Bain Capital Life Sciences Fund II, L.P. (Filed by)
Xilio Therapeutics (Subject)
| Form SC 13G/A | |
11/12/2024
3:50 PM | Rock Springs Capital Management LP (Filed by)
Xilio Therapeutics (Subject)
| Form SC 13G/A | |
11/12/2024
9:40 AM | FMR LLC (Filed by)
Xilio Therapeutics (Subject)
| Form SC 13G/A | |
11/07/2024
8:25 AM | Xilio Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
8:20 AM | Xilio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2024
8:36 PM | GKCC, LLC (Filed by)
Xilio Therapeutics (Subject)
| Form SC 13G | |
09/27/2024
8:00 PM | Chudnovsky Yekaterina (Reporting)
GKCC, LLC (Reporting)
Xilio Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
Get the Latest News and Ratings for XLO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Xilio Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
08/08/2024
6:45 AM | Xilio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
6:51 AM | Xilio Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/06/2024
7:00 PM | Frankenfield Christopher James (Reporting)
Xilio Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2024
6:46 AM | TAKEDA PHARMACEUTICAL CO LTD (Filed by)
Xilio Therapeutics (Subject)
| Form SC 13G/A | |
06/17/2024
3:30 PM | Curran Daniel J. (Reporting)
Xilio Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
3:30 PM | Clancy Paul J (Reporting)
Xilio Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
3:30 PM | Rossi Christina (Reporting)
Xilio Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
3:30 PM | ROSS ROBERT W. (Reporting)
Xilio Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
3:30 PM | Bonstein Sara (Reporting)
Xilio Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
3:30 PM | Xilio Therapeutics (Issuer)
Xu Yuan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
7:09 AM | Xilio Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/14/2024
6:45 AM | Xilio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2024
11:15 PM | Xilio Therapeutics (Filer)
| Form EFFECT | |
04/30/2024
4:09 PM | Xilio Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
04/15/2024
8:00 AM | Xilio Therapeutics (Filer)
| Form 424B5 | |
04/05/2024
3:31 PM | GILEAD SCIENCES, INC. (Filed by)
Xilio Therapeutics (Subject)
| Form SC 13G | |
04/05/2024
1:51 PM | Rock Springs Capital Management LP (Filed by)
Xilio Therapeutics (Subject)
| Form SC 13G/A | |
04/03/2024
5:48 PM | GILEAD SCIENCES, INC. (Reporting)
Xilio Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/03/2024
5:50 PM | GILEAD SCIENCES, INC. (Reporting)
Xilio Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
3:15 PM | Xilio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2024
3:20 PM | Xilio Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/28/2024
3:08 PM | Xilio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
6:55 AM | Xilio Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
1:12 PM | Rock Springs Capital Management LP (Filed by)
Xilio Therapeutics (Subject)
| Form SC 13G | |
02/09/2024
3:33 PM | Atlas Venture Associates Opportunity I, L.P. (Reporting)
Atlas Venture Associates Opportunity I, LLC (Reporting)
Atlas Venture Associates XI, L.P. (Reporting)
Atlas Venture Associates XI, LLC (Reporting)
Atlas Venture Fund XI, L.P. (Reporting)
Atlas Venture Opportunity Fund I, L.P. (Reporting)
Xilio Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
3:01 PM | Octagon Capital Advisors LP (Filed by)
Xilio Therapeutics (Subject)
| Form SC 13G/A | |
